<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR1">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Andersen</surname>
    <given-names>PI</given-names>
   </name>
   <name>
    <surname>Ianevski</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Lysvand</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Vitkauskiene</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Oksenych</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Bjørås</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Telling</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Lutsar</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Dampis</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Irie</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Tenson</surname>
    <given-names>T</given-names>
   </name>
  </person-group>
  <article-title>Discovery and development of safe-in-man broad-spectrum antiviral agents</article-title>
  <source>Int J Infect Dis</source>
  <year>2020</year>
  <volume>93</volume>
  <fpage>268</fpage>
  <lpage>276</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijid.2020.02.018</pub-id>
  <?supplied-pmid 7128205?>
  <pub-id pub-id-type="pmid">32081774</pub-id>
 </element-citation>
</ref>
